title: Esophageal carcinoma advances in treatment results for locally advanced disease: review.
abstract: The treatment results of patients with locally advanced esophageal carcinomas have evolved since the publication of the first trial of concurrent mitomycin C and 5-fluorouracil with radiotherapy (RT) in 1983. Subsequent studies refined and improved on the concurrent chemotherapy (chemo) with administration of cisplatin and 5-fluorouracil infusion (PF). Chemo (PF) before surgery improved overall survival (OS) in those patients in most of the randomized trials and in meta-analyses. Two courses of PF concurrent with irradiation followed by additional two courses of PF were superior to RT alone without surgery for both groups. Concurrent chemoradiotherapy followed by surgery was found to have statistically improved OS as compared with surgery only in randomized trials and meta-analyses. In most of these studies, it was found that those patients with pathologic complete response to the initial treatment(s) did better than those who had no improvement at all. Current treatment outcome for these diseases is disappointing; newer strategies including induction chemo with the optimal combination, proper dosage of each drug, and proper number of courses before concurrent chemoradiotherapy; improvement in RT; and immunotherapy with or without subsequent surgery are exciting and definitely need to be investigated in prospective randomized trial(s).
authors: Department of Radiation Oncology. Electronic address: Arnold_Herskovic@rush.edu.
authors: A
authors: A
authors: Herskovic
authors: Department of Radiation Oncology.
authors: W
authors: W
authors: Russell
authors: Department of Thoracic Surgery.
authors: M
authors: M
authors: Liptay
authors: Department of Section of Medical Oncology, Rush University Medical Center, Chicago.
authors: M J
authors: MJ
authors: Fidler
authors: Department of Medicine, Wm Beaumont Hospital, Royal Oak, USA.
authors: M
authors: M
authors: Al-Sarraf
mesh_terms: D002277:Carcinoma / Q000473:pathology / Q000628:therapy*; D059248:Chemoradiotherapy; D002755:Choice Behavior; D003131:Combined Modality Therapy; D013505:Digestive System Surgical Procedures / Q000706:statistics & numerical data; D018450:Disease Progression; D004938:Esophageal Neoplasms / Q000473:pathology / Q000628:therapy*; D006801:Humans; D008495:Medical Oncology / Q000379:methods / Q000639:trends; D035703:Therapies, Investigational / Q000009:adverse effects* / Q000379:methods